Clinical Trials in Tennessee

Showing 16681-16700 of 20,239 trials

A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

NCT00463021

Protocol HECT00306 aims to determine clinically appropriate doses of Hectorol (doxercalciferol capsules) when converting from Zemplar (paricalcitol injection) for the treatment of secondary hyperparathyroidism in Stage 5 chronic kidney disease on hemodialysis.

Secondary Hyperparathyroidism

Genzyme, a Sanofi Company36 participantsStarted Apr 2007

Downey, California, United States • Paramount, California, United States • Hudson, Florida, United States +5 more locations

COMPLETEDPhase 329 miles

Age-Related Eye Disease Study 2 (AREDS2)

NCT00345176

Oral supplementation with the Age-Related Eye Disease Study (AREDS) formulation (antioxidant vitamins C and E, beta carotene, and zinc) has been shown to reduce the risk of progression to advanced age-related macular degeneration (AMD). Observational data suggest that increased dietary intake of lutein + zeaxanthin (carotenoids), omega-3 long-chain polyunsaturated fatty acids (docosahexaenoic acid \[DHA\] + eicosapentaenoic acid \[EPA\]), or both might further reduce this risk. AREDS2 was designed to test whether adding lutein + zeaxanthin, DHA + EPA, or lutein + zeaxanthin and DHA + EPA to the AREDS formulation might further reduce the risk of progression to advanced AMD. A secondary goal was to test the effects of eliminating beta carotene and reducing zinc dose in the AREDS formulation.

National Eye Institute (NEI)4,203 participantsStarted Sep 2006

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Beverly Hills, California, United States +88 more locations

A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

Age-Related Eye Disease Study 2 (AREDS2)

Find Trials by Condition in Tennessee

Nebivolol in the Supine Hypertension of Autonomic Failure

Atrial Fibrillation/Flutter Outcome Risk Determination

The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants

Lung Screening Study

Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women

Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin

Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis

LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma

A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)

An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain

A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients

Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease

Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)

Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple Myeloma